Propofol protects cardiomyocytes from doxorubicin-induced toxic injury by activating the nuclear factor erythroid 2-related factor 2/glutathione peroxidase 4 signaling pathways

References

• Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfus-ion injury: a neglected therapeutic target. J Clin Invest. 2013;123(1):92–100.
   PubMed Web of Science ®Google Scholar
• Yang FY, Zhang L, Zheng Y, et al. Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling. Bioengineered. 2022;13(1):1377–1387.
   PubMed Web of Science ®Google Scholar
• Wallace KB, Sardao VA, Oliveira PJ. Mitochondrial determinants of doxorubicin-induced cardiomyopathy. Circ Res. 2020;126(7):926–941.
   PubMed Web of Science ®Google Scholar
• Zhang YW, Shi J, Li YJ, et al. Cardiomyocyte death in doxorubicin-induced cardiotoxicity. Arch Immunol Ther Exp (Warsz). 2009;57(6):435–445.
   PubMed Web of Science ®Google Scholar
• Reuter S, Gupta SC, Chaturvedi MM, et al. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010;49(11):1603–1616.
   PubMed Web of Science ®Google Scholar
• Miura T, Muraoka S, Ogiso T. Adriamycin-Fe3+-induced mitochondrial protein damage with lipid peroxidation. Biol Pharm Bull. 1995;18(4):514–517.
   PubMed Web of Science ®Google Scholar
• Fang X, Wang H, Han D, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A. 2019;116(7):2672–2680.
   PubMed Web of Science ®Google Scholar
• Hu C, Zhang X, Zhang N, et al. Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity. Clin Transl Med. 2020;10(3):e124.
   PubMed Web of Science ®Google Scholar
• Tadokoro T, Ikeda M, Ide T, et al. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight. 2020;5(9). DOI:10.1172/jci.insight.132747
   PubMed Web of Science ®Google Scholar
• Whelan RS, Kaplinskiy V, Kitsis RN. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol. 2010;72(1):19–44.
   PubMedGoogle Scholar
• Zhao H, Zhang X, Zheng Y, et al. Propofol Protects Rat Cardiomyocytes from Anthracycline-Induced Apoptosis by Regulating MicroRNA-181a In Vitro and In Vivo. Oxid Med Cell Longev. 2018;2018:2109216.
   PubMed Web of Science ®Google Scholar
• Zhao D, Li Q, Huang Q, et al. Cardioprotective effect of propofol against oxygen glucose deprivation and reperfusion injury in H9c2 cells. Oxid Med Cell Longev. 2015;2015:184938.
   PubMed Web of Science ®Google Scholar
• Li H, Tan J, Zou Z, et al. Propofol post-conditioning protects against cardiomyocyte apoptosis in hypoxia/reoxygenation injury by suppressing nuclear factor-kappa B translocation via extracellular signal-regulated kinase mitogen-activated protein kinase pathway. Eur J Anaesthesiol. 2011;28(7):525–534.
   PubMed Web of Science ®Google Scholar
• Rogers CA, Bryan AJ, Nash R, et al. Propofol cardioplegia: a single-center, placebo-controlled, randomized controlled trial. J Thorac Cardiovasc Surg. 2015;150(6):1610–1619 e1613.
   PubMed Web of Science ®Google Scholar
• Sun X, Gu J, Chi M, et al. Activation of PI3K-Akt through taurine is critical for propofol to protect rat cardiomyocytes from doxorubicin-induced toxicity. Can J Physiol Pharmacol. 2014;92(2):155–161.
   PubMed Web of Science ®Google Scholar
• Shinjo T, Tanaka T, Okuda H, et al. Propofol induces nuclear localization of Nrf2 under conditions of oxidative stress in cardiac H9c2 cells. PLoS One. 2018;13(4):e0196191.
   PubMed Web of Science ®Google Scholar
• Luo LF, Guan P, Qin LY, et al. Astragaloside IV inhibits Adriamycin-induced cardiac ferroptosis by enhancing Nrf2 signaling. Mol Cell Biochem. 2021;476(7):2603–2611.
   PubMed Web of Science ®Google Scholar
• Hu C, Zhang X, Song P, et al. Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway. Redox Biol. 2020;37:101747.
   PubMed Web of Science ®Google Scholar
• Song T, Yao Y, Wang T, et al. Tanshinone IIA ameliorates apoptosis of myocardiocytes by up-regulation of miR-133 and suppression of Caspase-9. Eur J Pharmacol. 2017;815:343–350.
   PubMed Web of Science ®Google Scholar
• Zhan L, Wang X, Zhang Y, et al. Benazepril hydrochloride protects against doxorubicin cardiotoxicity by regulating the PI3K/Akt pathway. Exp Ther Med. 2021;22(4):1082.
   PubMed Web of Science ®Google Scholar
• Wang X, Lian Z, Ge Y, et al. TRIM25 Rescues Against Doxorubicin-Induced Pyroptosis Through Promoting NLRP1 Ubiquitination. Cardiovasc Toxicol. 2021;21(10):859–868.
   PubMed Web of Science ®Google Scholar
• Guo R, Wu K, Chen J, et al. Exogenous Hydrogen Sulfide Protects against Doxorubicin-Induced Inflammation and Cytotoxicity by Inhibiting p38MAPK/NFκB Pathway in H9c2 Cardiac Cells. Cell Physiol Biochem. 2013;32(6):1668–1680.
   PubMedGoogle Scholar
• Colombo A, Cipolla C, Beggiato M, et al. Cardiac toxicity of anticancer agents. Curr Cardiol Rep. 2013;15(5):362.
   PubMed Web of Science ®Google Scholar
• Yu X, Sun X, Zhao M, et al. Propofol attenuates myocardial ischemia reperfusion injury partly through inhibition of resident cardiac mast cell activation. Int Immunopharmacol. 2018;54:267–274.
   PubMed Web of Science ®Google Scholar
• Chidambaran V, Costandi A, D’Mello A. Correction to: propofol: a Review of its Role in Pediatric Anesthesia and Sedation. CNS Drugs. 2018;32(9):873.
   PubMed Web of Science ®Google Scholar
• Holownia A, Mroz RM, Wielgat P, et al. Propofol protects rat astroglial cells against tert-butyl hydroperoxide-induced cytotoxicity; the effect on histone and cAMP-response-element-binding protein(CREB) signalling. J Physiol Pharmacol. 2009;60:63–69.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang N, Zhou S, et al. Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2. J Exp Clin Cancer Res. 2012;31(1):66.
   PubMedGoogle Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072.
   PubMed Web of Science ®Google Scholar
• Ichikawa Y, Ghanefar M, Bayeva M, et al. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Invest. 2014;124(2):617–630.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Dinkova-Kostova AT. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci. 2014;39(4):199–218.
   PubMed Web of Science ®Google Scholar
• Fan Z, Wirth AK, Chen D, et al. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis. 2017;6(8):e371.
   PubMedGoogle Scholar
• Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107.
   PubMed Web of Science ®Google Scholar
• Sun X, Ou Z, Chen R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63(1):173–184.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Cai S, Guo L, et al. Propofol induces mitochondrial-associated protein LRPPRC and protects mitochondria against hypoxia in cardiac cells. PLoS One. 2020;15(9):e0238857.
   PubMed Web of Science ®Google Scholar
• Mootha VK, Lepage P, Miller K, et al. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci U S A. 2003;100(2):605–610.
   PubMed Web of Science ®Google Scholar
• Michaud M, Barakat S, Magnard S, et al. Leucine-rich protein 130 contributes to apoptosis resistance of human hepatocarcinoma cells. Int J Oncol. 2011;38(1):169–178.
   PubMed Web of Science ®Google Scholar
• Ghiso NS, Lennon GG. lrp130 gene assigned to chromosome 2. Vitro Cell Dev Biol Anim. 1994;30(11):744.
   Google Scholar
• Song X, Long D. Nrf2 and Ferroptosis: a New Research Direction for Neurodegenerative Diseases. Front Neurosci. 2020;14:267.
   PubMed Web of Science ®Google Scholar
• Koleini N, Kardami E. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity. Oncotarget. 2017;8(28):46663–46680.
   PubMedGoogle Scholar
• Xie CL, Pan YB, Hu LQ, et al. Propofol attenuates hydrogenperoxide-induced apoptosis in human umbilical vein endothelial cells via multiple signaling pathways. Korean J Anesthesiol. 2015;68(5):488–495.
   PubMedGoogle Scholar
• Zhong H, Song R, Pang Q, et al. Propofol inhibits parthanatos via ROS-ER-calcium-mitochondria signal pathway in vivo and vitro. Cell Death Dis. 2018;9(10):932.
   PubMedGoogle Scholar
• Zhao H, Gu Y, Chen H. Propofol ameliorates endotoxininduced myocardial cell injury by inhibiting inflammation and apoptosis via the PPARgamma/HMGB1/NLRP3 axis. Mol Med Rep. 2021;23:1–1.
   Web of Science ®Google Scholar
• Conrad M, Angeli JP, Vandenabeele P, et al. Regulated necrosis: disease relevance and therapeutic opportunities. Nat Rev Drug Discov. 2016;15(5):348–366.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang Y, Cui M, et al. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nat Med. 2016;22(2):175–182.
   PubMed Web of Science ®Google Scholar